Pharmacokinetics and pharmacodynamics of multiple doses of omarigliptin in healthy subjects
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Omarigliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Merck & Co
- 14 Jun 2016 New trial record
- 26 May 2016 Results published in the Journal of Clinical Pharmacology